Roxane Articles
FTC files Amicus Brief, saying improper use of restricted drug distribution programs may impede generic competition
13 March 2013
Three drugmakers - Abbott, Roxane and Braun - to pay $421 million to settle false claims cases, says US Justice Dept
8 December 2010
Showing 1-2 of 2 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
